Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Robin

Showing results (151-160 of 298) with videos related to

Pageof 30
Sort By:
Targeted Oncology|November 13, 2013
Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trialNicolas Penel, Isabelle Ray-Coquard, Christine Bal-Mahieu, et al.
The Journal of Clinical Investigation|August 29, 2024
Deciphering bone marrow engraftment after allogeneic stem cell transplantation in humans using single-cell analysesJennifer Bordenave, Dorota Gajda, David Michonneau, et al.
The American Journal of Surgical Pathology|November 10, 2009
Adult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosisNathalie Stock, Frederic Chibon, Matthieu Bui Nguyen Binh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2020
Human-Derived α1-Antitrypsin is Still Efficacious in Heavily Pretreated Patients with Steroid-Resistant Gastrointestinal Graft-versus-Host DiseaseLivia Giannoni, Florence Morin, Marie Robin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 11, 2014
Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantationSophie Servais, Etienne Lengline, Raphaël Porcher, et al.
Transplantation|March 14, 2015
Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study From the French Society of Bone Marrow Transplantation and Cellular TherapyJordan Gauthier, Gandhi Damaj, Carole Langlois, et al.
Cancer|June 20, 2014
Long-term recurrence of soft tissue sarcomas: prognostic factors and implications for prolonged follow-upMaud Toulmonde, Axel Le Cesne, Jean Mendiboure, et al.
British Journal of Haematology|September 13, 2021
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMTAvichai Shimoni, Marie Robin, Simona Iacobelli, et al.
Cancer|July 22, 2014
Prognostic factors and impact of adjuvant treatments on local and metastatic relapse of soft-tissue sarcoma patients in the competing risks settingAntoine Italiano, Axel Le Cesne, Jean Mendiboure, et al.
Plos One|October 12, 2013
Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized dataRonald Brand, Hein Putter, Anja van Biezen, et al.
Pageof 30

Showing results (151-160 of 298) with videos related to

Sort By:
Pageof 30
Targeted Oncology|November 13, 2013
Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trialNicolas Penel, Isabelle Ray-Coquard, Christine Bal-Mahieu, et al.
The Journal of Clinical Investigation|August 29, 2024
Deciphering bone marrow engraftment after allogeneic stem cell transplantation in humans using single-cell analysesJennifer Bordenave, Dorota Gajda, David Michonneau, et al.
The American Journal of Surgical Pathology|November 10, 2009
Adult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosisNathalie Stock, Frederic Chibon, Matthieu Bui Nguyen Binh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2020
Human-Derived α1-Antitrypsin is Still Efficacious in Heavily Pretreated Patients with Steroid-Resistant Gastrointestinal Graft-versus-Host DiseaseLivia Giannoni, Florence Morin, Marie Robin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 11, 2014
Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantationSophie Servais, Etienne Lengline, Raphaël Porcher, et al.
Transplantation|March 14, 2015
Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study From the French Society of Bone Marrow Transplantation and Cellular TherapyJordan Gauthier, Gandhi Damaj, Carole Langlois, et al.
Cancer|June 20, 2014
Long-term recurrence of soft tissue sarcomas: prognostic factors and implications for prolonged follow-upMaud Toulmonde, Axel Le Cesne, Jean Mendiboure, et al.
British Journal of Haematology|September 13, 2021
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMTAvichai Shimoni, Marie Robin, Simona Iacobelli, et al.
Cancer|July 22, 2014
Prognostic factors and impact of adjuvant treatments on local and metastatic relapse of soft-tissue sarcoma patients in the competing risks settingAntoine Italiano, Axel Le Cesne, Jean Mendiboure, et al.
Plos One|October 12, 2013
Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized dataRonald Brand, Hein Putter, Anja van Biezen, et al.
Pageof 30